- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/90 - Oxygen atoms with acyclic radicals attached in position 2 or 3
Patent holdings for IPC class C07D 239/90
Total number of patents in this class: 154
10-year publication summary
|
8
|
7
|
5
|
9
|
10
|
16
|
7
|
5
|
11
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Inipharm, Inc. | 31 |
6 |
| Array BioPharma Inc. | 447 |
5 |
| Hoffmann-La Roche Inc. | 3783 |
4 |
| ATIR Holding S.A. | 16 |
4 |
| Gilead Sciences, Inc. | 2220 |
4 |
| Southern Research Institute | 204 |
4 |
| University of Kansas | 918 |
4 |
| University of Louisville Research Foundation, Inc. | 738 |
4 |
| Novartis AG | 10263 |
3 |
| F. Hoffmann-La Roche AG | 7836 |
3 |
| Pfizer Inc. | 3384 |
3 |
| Ache International (BVI) Ltd. | 6 |
3 |
| Emory University | 1719 |
3 |
| Oregon Health & Science University | 755 |
3 |
| Morphic Therapeutic, Inc. | 60 |
3 |
| Amgen Inc. | 4425 |
2 |
| The Trustees of Columbia University in the City of New York | 3643 |
2 |
| Takeda Pharmaceutical Company Limited | 2715 |
2 |
| Ache Laboratorios Farmaceuticos S.A. | 23 |
2 |
| Alcon, Inc. | 5848 |
2 |
| Other owners | 88 |